AstraZeneca

MedImmune, is a company that produces Synagis, a drug for the prevention of respiratory infections in infants, which accounted for US$ 1.06 billion of its US$ 1.2 billion in revenue for 2005, and FluMist, a nasal spray influenza vaccine introduced in 2004. MedImmune has over 120 drugs in development for conditions including lupus, COPD, asthma, and many types of cancer.

MedImmune

AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Denmark's national health agency temporarily suspends inoculations with the AstraZeneca Plc (NASDAQ: AZN) COVID-19 shot after blood clots formed in several people who had the jab, one of whom has reportedly died, reports CNBC. Søren Brostrøm, director of the National Board of Health in Denmark, insisted that the 14-day suspension was a precaution while investigations took place.

Denmark Stops Use Of AstraZeneca COVID-19 Shot Over Blood Clot Fears: CNBC

Denmark has announced that it is to temporarily suspend the use of the coronavirus vaccine developed by AstraZeneca and the University of Oxford.

Denmark suspends use of AstraZeneca vaccine over reports of blood clots

Denmark has stopped using AstraZeneca's COVID-19 vaccine because of potential serious side effects. The country has halted use of the vaccine after several cases of blood clots among vaccinated people, the Danish health authority said.

Denmark suspended the use of AstraZeneca's COVID-19 vaccine, citing the risk of blood clots

NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of AstraZeneca PLC (NASDAQ: AZN) between May 21, 2020 and November 20, 2020, inclusive (the "Class Period"), of the important March 29, 2021 lead plaintiff deadline. SO WHAT: If you purchased AstraZeneca securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEX

ROSEN, A LEADING LAW FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline – AZN

New York, New York--(Newsfile Corp. - March 8, 2021) - WHY:  Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of AstraZeneca PLC (NASDAQ: AZN) between May 21, 2020 and November 20, 2020, inclusive (the "Class Period"), of the important March 29, 2021 lead plaintiff deadline.SO WHAT: If you purchased AstraZeneca securities during the Class Period you may be entitled to compensation without payment of any out of pocket...

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline - AZN

Italy joins France and Germany in reversing its stance, giving green light for use of the shot in older people.

Italy approves AstraZeneca's COVID-19 vaccine for over 65s

South Korea is one of several countries to investigate the link between the Oxford-AstraZeneca shot and adverse reactions after vaccination.

South Korean Probe Finds No Link Between AstraZeneca Covid-19 Vaccine And Deaths

Moderna

Pfizer

BioNTech SE

CureVac B.V

Johnson & Johnson

Novavax

Sinovac Biotech

The companies in line for the biggest gains – and the shareholders who have already made fortunes

From Pfizer to Moderna: who's making billions from Covid-19 vaccines?

Europe is already vaccinating with AstraZeneca's product.

Why AstraZeneca May Dominate the European Vaccine Market

Boston, Massachusetts--(Newsfile Corp. - March 5, 2021) - The Thornton Law Firm announces that a class action lawsuit has been filed on behalf of investors of AstraZeneca PLC (NASDAQ: AZN). The case is currently in the lead plaintiff stage. Investors who purchased AZN stock or other securities between May 21, 2020 and November 20, 2020 may contact the Thornton Law Firm's investor protection team by visiting www.tenlaw.com/cases/AstraZeneca to submit their information. Investors may also email...

AstraZeneca Investor Alert: Class Action Lawsuit Filed

Preliminary data from a study conducted at the University of Oxford suggests that AstraZeneca Plc's (NASDAQ: AZN) COVID-19 vaccine is effective against the P1 or Brazilian variant, reports Reuters. The data indicate that the vaccine will not need modification to protect against the variant.

AstraZeneca's COVID-19 Vaccine Potentially Triggers Response Against Brazil Variant: Reuters

The AstraZeneca and University of Oxford coronavirus vaccine is effective against the Brazil variant, according to a report. But AstraZeneca stock remained muted Friday.

AstraZeneca Covid Vaccine Appears Effective Against Brazil Variant: Report

Europe's COVID-19 vaccine rollout has come under the spotlight again after the Italian government blocked a shipment of Oxford-AstraZeneca plc (NASDAQ: AZN) shots to Australia, reports CNBC. The EU is already struggling to keep up with the pace of inoculations per citizen compared to other advanced economies.

Italy Stops AstraZeneca COVID-19 Vaccine Exports To Australia: CNBC

This is the first use of new rules established by the European Union in January to better control the sourcing of COVID-19 vaccine doses within the bloc.

Italy's ban on AstraZeneca exports to Australia raises fears of vaccine nationalism

San Francisco, California--(Newsfile Corp. - March 4, 2021) - Hagens Berman urges AstraZeneca PLC (NASDAQ: AZN) investors to submit their losses now. A securities fraud class action has been filed and certain investors may have valuable claims.Class Period: May 21, 2020 - Nov. 20, 2020Lead Plaintiff Deadline: March 29, 2021Visit: www.hbsslaw.com/investor-fraud/AZNContact An Attorney Now: AZN@hbsslaw.com 844-916-0895AstraZeneca PLC (NASDAQ: AZN) Securities Fraud Class Action:The complaint alleges tha

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts AstraZeneca (AZN) Investors to Securities Fraud Lawsuit Application Deadline, Encourages Investors Who Suffered Losses to Contact the Firm

The European Commission, the institution leading the purchase agreements, has been blamed for not securing enough vaccines.

Italy reportedly blocks shipment of AstraZeneca Covid vaccine destined for Australia

NEW YORK, March 04, 2021 (GLOBE NEWSWIRE) -- Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of AstraZeneca PLC (NASDAQ: AZN) between May 21, 2020 and November 20, 2020, inclusive (the “Class Period”).

MARCH 29 DEADLINE: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against AstraZeneca PLC – AZN

NEW YORK, March 03, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of AstraZeneca PLC (NASDAQ: AZN) between May 21, 2020 and November 20, 2020, inclusive (the "Class Period"), of the important March 29, 2021 lead plaintiff deadline.

AZN BREAKING ALERT: ROSEN, A LEADING LAW FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline – AZN

Costco

Lockheed Martin

PepsiCo

Procter & Gamble

Walmart

Stocks that are worth considering for retirement investors. Low beta stocks with strong fundamentals and a healthy dividend yield.

7 Stocks for Any Retiree to Consider

Pharma giant AstraZeneca sold its stake in Moderna for more than $1 billion last year as the upstart biotech firm's COVID-19 vaccine thrust it into the spotlight. AstraZeneca quietly revealed the move in its February annual report, which said the Moderna sale accounted for “a large proportion” of the roughly $1.4 billion it raked in.

AstraZeneca cashed out Moderna stake for $1 billion in 2020

The Pfizer-BioNTech and Oxford-AstraZeneca coronavirus vaccines are both highly effective at preventing over-80s from being admitted to hospital, according to a new study.

Pfizer and AstraZeneca vaccines 'highly effective' at preventing hospital admissions in over-80s

AstraZeneca Just Sold Its Moderna Stock: Should You?

AstraZeneca plc (LON:AZN) said that the US District Court for the Northern District of West Virginia has decided in its favour in litigation against Mylan and Kindeva. The court determined that asserted claims in three of AstraZeneca's patents protecting asthma treatment Symbicort in the US are not invalid.

AstraZeneca says US court rules in its favour for Symbicort litigation

The chief of the country's public health body urged calm and said that no deaths have yet been confirmed to have a direct link to the vaccine.

South Korea Investigating Deaths Of Two Long Term Care Patients Who Received AstraZeneca Vaccine

U.K. scientists are out with a study that could ease concerns about giving older adults AstraZeneca's Covid-19 vaccine.

News for AstraZeneca Stock (AZN)